The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.88BCNY
279.83M · vs all stocks (USD)
Updated Sep 18, 2026
Revenue (TTM)
3.54BCNY
528.72M · vs all stocks (USD)
Updated Sep 18, 2026
Profit Margin
-46.33%
Updated Sep 18, 2026
Beta
0.3890x
vs all stocks
Updated Sep 18, 2026
52-Week Change
5.22%
vs all stocks
Updated Sep 18, 2026
Market Capitalization
1.88BCNY
279.83M · vs all stocks (USD)
Updated Sep 18, 2026
Enterprise Value
6.43BCNY
958.81M · vs all stocks (USD)
Updated Sep 18, 2026
Price to Sales (TTM)
0.5240x
Updated Sep 18, 2026
Enterprise to Revenue
1.81x
Updated Sep 18, 2026
Enterprise to EBITDA
-12.84x
Updated Sep 18, 2026
Gross Margin
1.88%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -10.21%.Updated Sep 18, 2026
Profit Margin
-46.33%
Updated Sep 18, 2026
Operating Margin
-24.37%
Updated Sep 18, 2026
Return on Assets (TTM)
-4.08%
Updated Sep 18, 2026
Revenue (TTM)
3.54BCNY
528.72M · vs all stocks (USD)
Updated Sep 18, 2026
Revenue per Share (TTM)
7.62CNYUpdated Sep 18, 2026
Quarterly Revenue Growth
-56.10%
Updated Sep 18, 2026
Gross Profit (TTM)
-361.88MCNY
-53.98M · vs all stocks (USD)
Updated Sep 18, 2026
EBITDA (TTM)
-500.62MCNY
-74.67M · vs all stocks (USD)
Updated Sep 18, 2026
Net Income (TTM)
-1.64BCNY
-244.96M · vs all stocks (USD)
Updated Sep 18, 2026
Operating Cash Flow (TTM)
-600.11MCNY
-89.51M · vs all stocks (USD)
Updated Sep 18, 2026
Levered Free Cash Flow (TTM)
183.74MCNY
27.41M · vs all stocks (USD)
Updated Sep 18, 2026
Payout Ratio
0.00%
Updated Sep 18, 2026
Minority Interest (Equity)
390.11MCNYFY2025 · Dec 31, 2025
Revenue
5.90BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
5.67BCNYFY2025 · Dec 31, 2025
Gross Profit
234.68MCNYFY2025 · Dec 31, 2025
Operating Income
103.68MCNY
15.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-915.69MCNYFY2025 · Dec 31, 2025
Income Tax Expense
7.24MCNYFY2025 · Dec 31, 2025
Net Income
-922.93MCNYFY2025 · Dec 31, 2025
EBIT
-654.86MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-72.71MCNYFY2025 · Dec 31, 2025
Research & Development
0.00CNYFY2025 · Dec 31, 2025
Selling, General & Administrative
54.86MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
27.85MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.36MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
260.83MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.93CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.93CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
465.51MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
465.51MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-922.93MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
26.45MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-1.42BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.44BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
77.10MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-922.93MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
256.97MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-865.07MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
109.45MCNYFY2025 · Dec 31, 2025
Capital Expenditures
16.56MCNYFY2025 · Dec 31, 2025
Net Acquisitions
5.84KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-315.60KCNYFY2025 · Dec 31, 2025
Sale of Investments
3.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
19.25MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.88BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.87BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-215.56MCNYFY2025 · Dec 31, 2025
Other Financing Charges
202.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.47MCNYFY2025 · Dec 31, 2025
Shares Outstanding
465.52MSharesUpdated Sep 18, 2026
Float Shares
357.72MSharesUpdated Sep 18, 2026
% Held by Insiders
22.60%
vs all stocks
Updated Sep 18, 2026
% Held by Institutions
1.78%
vs all stocks
Updated Sep 18, 2026
Total Cash (MRQ)
229.42MCNY
34.22M · vs all stocks (USD)
Updated Sep 18, 2026
Total Cash per Share (MRQ)
0.4930CNYUpdated Sep 18, 2026
Total Debt (MRQ)
4.43BCNY
660.22M · vs all stocks (USD)
Updated Sep 18, 2026
Current Ratio (MRQ)
0.7840x
Updated Sep 18, 2026
Book Value per Share (MRQ)
-1.57CNYUpdated Sep 18, 2026
Total Assets
8.28BCNY
1.24B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.91BCNYFY2025 · Dec 31, 2025
Total Liabilities
7.77BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.37BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.39BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
5.38BCNYFY2025 · Dec 31, 2025
Cash
48.13MCNYFY2025 · Dec 31, 2025
Cash Equivalents
451.53MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
499.66MCNYFY2025 · Dec 31, 2025
Accounts Receivable
319.09MCNYFY2025 · Dec 31, 2025
Inventory
2.24BCNYFY2025 · Dec 31, 2025
Accounts Payable
931.64MCNYFY2025 · Dec 31, 2025
Short-term Debt
2.51BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
81.92MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.86BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
79.29MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
465.52MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.42BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
510.77MCNY
76.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.54CNYUpdated Sep 18, 2026
52-Week High
8.75CNYUpdated Sep 18, 2026
52-Week Change
5.22%
vs all stocks
Updated Sep 18, 2026
Beta
0.3890x
vs all stocks
Updated Sep 18, 2026
50-Day MA
3.59CNYUpdated Sep 18, 2026
200-Day MA
4.41CNYUpdated Sep 18, 2026
Avg 10-Day Volume
13.34MSharesUpdated Sep 18, 2026
Avg 30-Day Volume
14.51MSharesUpdated Sep 18, 2026
Diluted EPS (TTM)
-3.53CNYUpdated Sep 18, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.29: distress zoneCritical
Altman Z-Score: 0.29
Supply Chain
Upstream position: supplies 7 industries, depends on 1Notable
Outgoing: 7.00Incoming: 1.00
Scale
Levered free cash flow is $27.41M, above the global median of $18.73MNotable